Horizon Technology Finance Announces Third Quarter 2026 Financial Results

Horizon Technology Finance Corp (HRZN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Horizon Technology Finance Announces Third Quarter 2026 Financial Results - Third Quarter 2026 Net Investment Income per Share of $0.19; NAV per Share of $5.56 - - Debt Portfolio Yield of 14.7% - - Grows Committed, Approved and Awarded Backlog by 14% Sequentially to

Event · Earnings
Also in this documentDividend · regular · $0.06Buyback · $20M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 5, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HRZN
Neutral
high confidence
Mentioned
$HRZN
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HRZNNeutralMed
01

Why it matters

The quarter's lower net investment income and NAV per share suggest short‑term pressure, but the share repurchase and fee waiver provide upside catalysts.

02

Market read

Primary earnings disclosure for a niche credit fund; relevance mainly to fund investors and credit‑focused traders.

03

What to watch

The fee waiver from Monroe Capital reduces expense pressure, which may improve future profitability.

Relevance 7/10Novelty 8/10Timing: post-market today
AlphAI · Earnings readHRZN · Third Quarter 2026 · ended September 30, 2026

Third Quarter 2026 Net Investment Income per Share of $0.19; NAV per Share of $5.56; Debt Portfolio Yield of 14.7%; Grows Committed, Approved and Awarded Backlog by 14% Sequentially to $351 Million at Quarter End

→Mixed quarter

Net investment income, total investment income and portfolio yield were lower than the prior-year quarter, while substantial realized and unrealized investment losses drove a net decrease in net assets. The company funded $98.4 million of loans, increased backlog sequentially and repurchased $10.0 million of stock.

EPS · other
$0.24

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total investment income, three months ended September 30GAAP$24.1M––
Total investment income, nine months ended September 30GAAP$73.2M––
Net expenses, three months ended September 30GAAP$11.5M––
Net expenses, nine months ended September 30GAAP$43.7M––
Net investment income, three months ended September 30GAAP$12.3M––
Net investment income per basic share, three months ended September 30GAAP$0.19 per basic share––
Net investment income, nine months ended September 30GAAP$28.6M––
Net realized loss on investments, three months ended September 30GAAP$11.3M––
Net unrealized depreciation on investments, three months ended September 30GAAP$29.1M––
Net decrease in net assets resulting from operations, three months ended September 30GAAP$28.2M––
Net decrease in net assets resulting from operations per common share, basic, three months ended September 30GAAP$(0.43)––
Net decrease in net assets resulting from operations per common share, diluted, three months ended September 30GAAP$(0.43)––
Total investment portfolioGAAP$650.3 million as of September 30, 2026––
Debt portfolio fair valueGAAP$621.2M––
Annualized portfolio yield on debt investmentsother14.7%––
Net asset valueGAAP$362.1M––
Net asset value per common shareGAAP$5.56––
Debt investments weighted average credit ratingother2.3 as of September 30, 2026––
Debt investments rated 5 at fair valueother$18.8M––
Debt investments rated 4 at fair valueother$54.9M––
Undistributed spillover income per shareother$0.24 per share as of September 30, 2026––
Distributions declared per share, three months ended September 30GAAP$0.27––
Distributions declared per share, nine months ended September 30GAAP$0.72––

Capital returns

  • Repurchased 2,033,991 shares of common stock at a weighted-average price of $4.90 per share during the quarter ended September 30, 2026, at a total cost of $10.0 million.
  • From inception of the stock repurchase program through September 30, 2026, repurchased 3,566,678 shares at a weighted average price of $5.06, at a total cost of $18.1 million.
  • The stock repurchase program allows repurchases of up to a total of $20 million of common stock.
  • Declared monthly cash distributions of $0.06 per share payable in each of January, February and March 2027, totaling $0.18 per share.

What drove it

  • Funded nine loans totaling $98.4 million during the quarter.
  • Committed, approved and awarded backlog grew 14% sequentially to $351 million at quarter end.
  • Total investment income declined primarily due to lower interest income on debt investments.
  • The annualized yield decreased primarily due to recognition and capitalization of accrued, but previously unrecorded interest income in connection with settlement of two debt investments previously on non-accrual status during the three months ended September 30, 2025.
  • Net expenses declined primarily due to a $0.7 million decrease in the base management fee and a $0.1 million decrease in interest expense, partially offset by a $0.3 million increase in professional fees.
  • Horizon’s Advisor waived $1.0 million of base management fees for the quarter under the Fee Waiver.
  • The company experienced liquidity events from six portfolio companies.

Concerns

  • Net investment income was $12.3 million, or $0.19 per basic share, compared with $14.0 million, or $0.32 per basic share, for the prior-year period.
  • Net unrealized depreciation on investments was $29.1 million, compared with net unrealized appreciation on investments of $40.5 million in the prior-year period.
  • Net decrease in net assets resulting from operations was $28.2 million, or $0.43 per basic share.
  • NAV per share was $5.56, compared with $7.12 as of September 30, 2025 and $6.98 as of December 31, 2025.
  • Seven debt investments were rated 5, with aggregate cost of $65.9 million and aggregate fair value of $18.8 million; four debt investments were rated 4, with aggregate cost of $77.3 million and aggregate fair value of $54.9 million.
  • After paying distributions of $0.27 per share and earning net investment income of $0.19 per share for the three months ended September 30, 2026, undistributed spillover income was $0.24 per share.

What to watch

  • Execution against the $351 million committed, approved and awarded backlog.
  • The company’s management of stressed debt investments, which management said continued to impact NAV per share in the quarter.
  • Performance and valuation changes in investments rated 4 and 5.
  • Portfolio growth after the October 30, 2026 funding of a $10.0 million debt investment to Pelthos Therapeutics, Inc. and a $0.1 million debt investment to Volt Bidco, Inc.
  • The Fee Waiver, which is in effect until the end of the second quarter of 2027 and is capped at $1.0 million per applicable quarter.
  • The relationship between NII, declared distributions and spillover income.

Balance sheet and cash flow

  • Available liquidity was $210.9 million as of September 30, 2026, consisting of $107.8 million in cash and money market funds and $103.1 million available under existing credit facility commitments.
  • Cash was $20.0 million and investments in money market funds were $85.1 million as of September 30, 2026.
  • Total assets were $778.7 million and total liabilities were $416.6 million as of September 30, 2026.
  • Borrowings were $402.7 million as of September 30, 2026, compared with $473.0 million as of December 31, 2025.
  • Net debt to equity leverage ratio was 82%, below the Company’s 120% targeted leverage.
  • Asset coverage ratio for borrowed amounts was 189%.
  • There was no outstanding principal balance under the $150.0 million revolving credit facility as of September 30, 2026.
  • Outstanding principal balances as of September 30, 2026 included $166.5 million of Class A Notes at 6.72%, $14.5 million of Class B Notes at 7.86%, $90.0 million under the $150.0 million senior secured credit facility at 7.21%, $2.8 million of 7.125% convertible notes due 2031, and $16.5 million of 5.50% convertible notes due 2030.

Analysis

Horizon reported third-quarter net investment income of $12.3 million, or $0.19 per basic share, compared with $14.0 million, or $0.32 per basic share, in the prior-year period. Total investment income was $24.1 million versus $26.3 million, with the company attributing the decline primarily to lower interest income on debt investments. The annualized yield on average debt investments was 14.7%, compared with 18.6% in the prior-year quarter. Net expenses were $11.5 million versus $12.0 million, helped by a $1.0 million management-fee waiver.

Investment activity was active, with nine loans funded totaling $98.4 million and committed, approved and awarded backlog increasing 14% sequentially to $351 million. The total portfolio ended at $650.3 million, including $621.2 million of secured loans. The company also reported six portfolio-company liquidity events. Subsequent to quarter end, Glass Routes prepaid $7.5 million, Hometeam Technologies repaid $3.5 million, and Horizon funded $10.0 million to Pelthos Therapeutics, Inc. and $0.1 million to Volt Bidco, Inc.

Portfolio valuation was the central negative factor. Horizon recorded a $11.3 million net realized loss on investments and $29.1 million of net unrealized depreciation on investments, resulting in a $28.2 million net decrease in net assets from operations, or $0.43 per basic share. NAV was $362.1 million, or $5.56 per share. The company stated that stressed debt investments continued to impact NAV per share. Under the revised rating scale, seven investments rated 5 had an aggregate fair value of $18.8 million, while four rated 4 had an aggregate fair value of $54.9 million.

Liquidity stood at $210.9 million, including $107.8 million in cash and money market funds and $103.1 million of available credit-facility capacity. Net debt to equity leverage was 82%, below the stated 120% target, and asset coverage was 189%. The company repurchased 2,033,991 shares for $10.0 million at a weighted-average price of $4.90. It declared $0.06 per-share monthly distributions for January, February and March 2027, totaling $0.18 per share, while reported spillover income was $0.24 per share after third-quarter distributions of $0.27 per share.

Management, verbatim

We were pleased to grow our debt investment portfolio for the fourth consecutive quarter, funding nine loans totaling $98.4 million, and delivering NII which once again covered our regular distributions.

Mike Balkin, Chief Executive Officer of Horizon

While we work on growing our portfolio, we remain focused on rigorously managing our stressed debt investments, which continued to impact our NAV per share in the quarter.

Mike Balkin, Chief Executive Officer of Horizon

As we close out 2026, with our strong balance sheet and increasingly robust pipeline, we believe we are in an excellent position to further grow our portfolio and drive long-term value creation for shareholders.

Mike Balkin, Chief Executive Officer of Horizon

Not in the filing

stated, not guessed
  • Forward financial guidance for revenue, gross margin, operating expenses, tax rate, NII, EPS, NAV, portfolio yield, originations, leverage or other operating metrics was not provided.
  • Prior-period outlook was not provided.
  • Segment revenue and segment operating results were not reported.
  • Gross profit, gross margin, operating income, operating margin, net income, conventional earnings per share, operating cash flow and free cash flow were not reported.
  • Non-GAAP financial measures were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

Horizon Technology Finance Corp (HRZN) is a closed‑end fund focused on stressed‑debt investments, affiliated with Monroe Capital.

Company-level read

Ticker impact

$HRZNNeutralHigh confidence
Context

Q3 2026 earnings release showing net investment income of $0.19 per share, NAV $5.56, and a share repurchase of 2.03M shares.

Expected impact

modest downside pressure as investors digest lower income and NAV, partially offset by share repurchase support

Evidence & confidence

The report is the first disclosure of the quarter's results; the decline in NII and NAV per share signals weaker performance, while the buyback may limit the drop.

Market effects

Results reflect broader trends in stressed debt investment funds, potentially influencing peer fund valuations.

Limited to U.S. listed closed-end fund space; no broader regional effect.

Minimal global impact beyond niche credit fund investors.

Counterpoint

Despite the earnings miss, the fund's strong balance sheet and pipeline could position it for outperformance if credit markets improve.

Key entities

  • Mike Balkin

    Chief Executive Officer of Horizon, quoted on quarterly performance.

  • Monroe Capital

    Parent affiliate providing strategic support and fee waiver.

Every HRZN earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$HRZNMed

Horizon Tech Finance (HRZN) Q3 2026 Earnings Call Transcript

Horizon Tech Finance (HRZN) reported Q3 2026 earnings, growing its debt investment portfolio to $650M and funding 9 investments totaling $98M. NAV per share fell to $5.56 due to write-downs, but NII per share was $0.19. The company declared monthly distributions of $0.06 per share for early 2027 and repurchased 2M shares. Portfolio yield was 14.7%, among the highest in the BDC industry. The company faces credit pressures but remains optimistic about long-term growth.

$HRZNMed

Horizon Technology Finance Q3 Earnings Call Highlights

Horizon Technology Finance reported Q3 investment income of $24.1M, down from $26.3M YoY, with net investment income of $0.19 per share. Its debt portfolio yield was 14.7%, and it declared monthly distributions of $0.06 per share for early 2027. The company had $211M in liquidity and repurchased 2M shares at $4.90 each. It appointed Manuel Henriquez as chief growth and strategy officer.

$HRZNMed

Horizon Technology Finance Q2 Earnings Call Highlights

Horizon Technology Finance (HRZN) reported Q2 NAV per share of $6.23, down from $6.98 in Q1 and $6.75 a year earlier, mainly tied to Soli-related write-downs. Investment income was $25.0M; expenses rose to $17.4M due to $4.4M merger costs. Net investment income was $0.11/share. The board declared $0.06 monthly regular plus $0.03 special for Oct-Dec 2026 and authorized an additional $20M buyback.

$HRZNMed

Horizon Technology Finance Announces Second Quarter 2026 Financial Results

Horizon Technology Finance Corp (HRZN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Horizon Technology Finance Announces Second Quarter 2026 Financial Results - Second Quarter 2026 Net Investment Income per Share of $0.11 (Inclusive of $0.07 per Share of Non-Recurring Merger Expenses); NAV per Share of $6.23 - - Debt Portfolio Yield of 14.9% - - End